ADA2019: Adocia will be presenting 1 oral Presentation and 1 Poster next June 9th & 10th – in San Francisco – USA

Adocia will be presenting two abstracts at the 79th Scientific Sessions of the American Diabetes Association® ADA2019.

Join us on June 9th and June 10th for these presentations in San Francisco – USA!

Details of the accepted abstracts are presented below:

  • Oral Presentation #150-OR: Biochaperone Pramlintide Insulin (BCPramIns), A New Co-formulation Of Pramlintide (pram) And Human Insulin (ins), Improves Post-prandial Blood Glucose (BG) Versus Both Separate Injections Of Pram+Ins And Insulin Lispro (lis) in Subjects With T1D

Presenting Author: Dr. Grégory Meiffren

Session: Innovations in Insulin Therapy

Date and Time: Sunday, June 09 at 9:30 AM PST

Location: Room S-303 (South, Level 3)

 

  • Poster #2008-P: BioChaperone Glucagon Exenatide (BC Glu Exe), a Stable Combination of Glucagon (Glu) and Exenatide (Exe) Achieved Larger Body Weight (BW) Loss than Exe Alone in DIO Mice

Presenting Author: Dr. Martin Gaudier

Session: 22-A Obesity-Animal

Date and Time: Monday, June 10 at 12:00 PM – 1:00 PM PST

Location: Poster Hall

 

Place: Moscone Center, San Francisco, CA, USA

 

To read more: https://ada2019.org/ and https://www.adocia.com/

ADA2019

AdociaInnovation

Diabetes

Obesity

BioChaperone